Clinical Trial Update: Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating PXT00864 in patients with mild Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PXT00864

Snippet

Sponsor: Pharnext S.C.A. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED